Urinary exosomal microRNA profiling in intermediate-risk prostate cancer

Abstract MicroRNAs (miRNAs) of urine exosomes have emerged as biomarkers for urological cancers, owing to their high stability. MiRNAs have been linked to factors associated with aggressive prostate cancer such as biochemical recurrence (BCR) and metastasis. In this study, we aimed to identify urina...

Descrición completa

Detalles Bibliográficos
Main Authors: Mee Young Kim, Hyunwoo Shin, Hyong Woo Moon, Yong Hyun Park, Jaesung Park, Ji Youl Lee
Formato: Artigo
Idioma:English
Publicado: Nature Portfolio 2021-04-01
Series:Scientific Reports
Acceso en liña:https://doi.org/10.1038/s41598-021-86785-z
_version_ 1828978019936501760
author Mee Young Kim
Hyunwoo Shin
Hyong Woo Moon
Yong Hyun Park
Jaesung Park
Ji Youl Lee
author_facet Mee Young Kim
Hyunwoo Shin
Hyong Woo Moon
Yong Hyun Park
Jaesung Park
Ji Youl Lee
author_sort Mee Young Kim
collection DOAJ
description Abstract MicroRNAs (miRNAs) of urine exosomes have emerged as biomarkers for urological cancers, owing to their high stability. MiRNAs have been linked to factors associated with aggressive prostate cancer such as biochemical recurrence (BCR) and metastasis. In this study, we aimed to identify urinary exosomal miRNAs as prognostic markers associated with BCR in intermediate-risk prostate cancer. We profiled the expression levels of miRNAs via next generation sequencing in urinary exosomes from 21 non-BCR patients and 6 BCR patients of intermediate-risk prostate cancer. A total of 21 urinary exosomal miRNAs were found to be differentially expressed (> twofold) in BCR patients compared to non-BCR patients. For external validation, we validated these results using quantitative reverse transcription PCR in an independent cohort of 28 non-BCR patients and 26 BCR patients. A validation analysis revealed that three miRNAs (miR-26a-5p, miR-532-5p, and miR-99b-3p) were upregulated in exosomes from BCR patients. The univariate and multivariate Cox regression analyses showed that miR-532-5p was an important predictive factor for BCR of intermediate-risk prostate cancer. In conclusion, miR-532-5p in urine exosomes might be a potential biomarker for predicting BCR, which is a poor prognosis in patients with intermediate-risk prostate cancer. Further research is needed on the biological functions and mechanisms of this miRNA.
first_indexed 2024-12-14T15:10:08Z
format Article
id doaj.art-a4d0b5e1a07b490e901b52c3215811f1
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T15:10:08Z
publishDate 2021-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-a4d0b5e1a07b490e901b52c3215811f12022-12-21T22:56:36ZengNature PortfolioScientific Reports2045-23222021-04-011111710.1038/s41598-021-86785-zUrinary exosomal microRNA profiling in intermediate-risk prostate cancerMee Young Kim0Hyunwoo Shin1Hyong Woo Moon2Yong Hyun Park3Jaesung Park4Ji Youl Lee5Catholic Cancer Research Institute, College of Medicine, The Catholic University of KoreaDepartment of Mechanical Engineering, Pohang University of Science and TechnologyDepartment of Urology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDepartment of Urology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDepartment of Mechanical Engineering, Pohang University of Science and TechnologyCatholic Cancer Research Institute, College of Medicine, The Catholic University of KoreaAbstract MicroRNAs (miRNAs) of urine exosomes have emerged as biomarkers for urological cancers, owing to their high stability. MiRNAs have been linked to factors associated with aggressive prostate cancer such as biochemical recurrence (BCR) and metastasis. In this study, we aimed to identify urinary exosomal miRNAs as prognostic markers associated with BCR in intermediate-risk prostate cancer. We profiled the expression levels of miRNAs via next generation sequencing in urinary exosomes from 21 non-BCR patients and 6 BCR patients of intermediate-risk prostate cancer. A total of 21 urinary exosomal miRNAs were found to be differentially expressed (> twofold) in BCR patients compared to non-BCR patients. For external validation, we validated these results using quantitative reverse transcription PCR in an independent cohort of 28 non-BCR patients and 26 BCR patients. A validation analysis revealed that three miRNAs (miR-26a-5p, miR-532-5p, and miR-99b-3p) were upregulated in exosomes from BCR patients. The univariate and multivariate Cox regression analyses showed that miR-532-5p was an important predictive factor for BCR of intermediate-risk prostate cancer. In conclusion, miR-532-5p in urine exosomes might be a potential biomarker for predicting BCR, which is a poor prognosis in patients with intermediate-risk prostate cancer. Further research is needed on the biological functions and mechanisms of this miRNA.https://doi.org/10.1038/s41598-021-86785-z
spellingShingle Mee Young Kim
Hyunwoo Shin
Hyong Woo Moon
Yong Hyun Park
Jaesung Park
Ji Youl Lee
Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
Scientific Reports
title Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
title_full Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
title_fullStr Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
title_full_unstemmed Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
title_short Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
title_sort urinary exosomal microrna profiling in intermediate risk prostate cancer
url https://doi.org/10.1038/s41598-021-86785-z
work_keys_str_mv AT meeyoungkim urinaryexosomalmicrornaprofilinginintermediateriskprostatecancer
AT hyunwooshin urinaryexosomalmicrornaprofilinginintermediateriskprostatecancer
AT hyongwoomoon urinaryexosomalmicrornaprofilinginintermediateriskprostatecancer
AT yonghyunpark urinaryexosomalmicrornaprofilinginintermediateriskprostatecancer
AT jaesungpark urinaryexosomalmicrornaprofilinginintermediateriskprostatecancer
AT jiyoullee urinaryexosomalmicrornaprofilinginintermediateriskprostatecancer